• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 451/04 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropaneCyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring system

Patent holdings for IPC class C07D 451/04

Total number of patents in this class: 271

10-year publication summary

12
22
19
25
28
18
20
23
7
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Theravance Biopharma R&D IP, LLC
458
14
Remix Therapeutics Inc.
79
10
Skyhawk Therapeutics, Inc.
110
9
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
823
8
Novartis AG
10847
7
Bristol-myers Squibb Company
4878
7
Purdue Pharma L.P.
499
7
Janssen Pharmaceutica N.V.
3395
6
Curza Global, LLC
29
6
Shionogi & Co., Ltd.
858
6
University of Utah Research Foundation
1807
6
Merck Patent GmbH
5830
5
Rigel Pharmaceuticals, Inc.
539
5
ACADIA Pharmaceuticals Inc.
205
4
Astellas Pharma Inc.
1085
4
BioMarin Pharmaceutical Inc.
376
4
Enanta Pharmaceuticals, Inc.
428
4
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
302
4
The University of Edinburgh
27
4
Shanghai Hansoh Biomedical Co., Ltd.
262
4
Other owners 147